AMGN

Amgen Inc

245.55 2.25 (0.92%)

Отсроченные курсы NASDAQ, в USD Рынок закрыт

Сделка

245.09

245.72

Созданная в 1980 году, биотехнологическая компания Amgen Inc занимается открытием, разработкой, производством и реализацией лекарств от тяжелых заболеваний. Она специализируется на лечении людей и на разработке новых лекарств, основанных на клеточной и молекулярной биологии. Фирма работает на международном... Показать подробности

Последний месяц

ТОП

@Nezatron

Словения

сутки назад

🟥𝐄𝐧𝐝 𝐨𝐟 𝐓𝐡𝐞 𝐑𝐞𝐝 𝐉𝐮𝐧𝐞 𝐚𝐧𝐝 𝐒𝐭𝐚𝐫𝐭 𝐨𝐟 𝐓𝐡𝐞 𝐄𝐚𝐫𝐧𝐢𝐧𝐠𝐬 𝐒𝐞𝐚𝐬𝐨𝐧💰 Hello copiers and followers! In the first half of the year we went through some really rough economical and geopolitical shocks. I believe that emotionally it was quite difficult for all of us, since... Показать подробности

Перевод

22-Q2 Quarterly Conference Call with eToro Elite Popular investor Nezatron

www.youtube.com

Hello everyone! In this video, I chat about my investing career, portfolio, and future views. See my eToro portfolio at 👉: https://www.etoro.com/people/neza...

@DeepNews

eToro

4 суток назад

$AMGN (Amgen Inc) Wealth Enhancement Advisory Services LLC Purchases Shares of 853 Amgen Inc. (NASDAQ:AMGN) Wealth Enhancement Advisory Services LLC purchased a new stake in Amgen Inc. (NASDAQ:AMGN) during the first quarter, Holdings Channel reports. www.defenseworld.net/2022/06/30/wealth-enhancement-advisory-services-llc-purchases-shares-of-853-amgen-inc-nasdaqamgn.html

Перевод

Wealth Enhancement Advisory Services LLC Purchases Shares of 853 Amgen Inc. (NASDAQ:AMGN)

www.defenseworld.net

Wealth Enhancement Advisory Services LLC purchased a new stake in Amgen Inc. (NASDAQ:AMGN – Get Rating) during the first quarter, Holdings Channel reports. The firm purchased 853 shares of the medical research company’s stock, valued at approximately $209,000. Other institutional investors have also recently modified their holdings of the company. Dixon Hughes Goodman Wealth Advisors […]

@DeepNews

eToro

9 суток назад

$AMGN (Amgen Inc) Amgen (NASDAQ:AMGN) Earns “Outperform” Rating from Oppenheimer Oppenheimer reiterated their outperform rating on shares of Amgen (NASDAQ:AMGN) in a research note issued to investors on Friday. They currently have a $290.00 price target on the medical research company’s stock. www.defenseworld.net/2022/06/25/amgen-nasdaqamgn-earns-outperform-rating-from-oppenheimer.html

Перевод

Amgen (NASDAQ:AMGN) Earns “Outperform” Rating from Oppenheimer

www.defenseworld.net

Oppenheimer reiterated their outperform rating on shares of Amgen (NASDAQ:AMGN – Get Rating) in a research note issued to investors on Friday. They currently have a $290.00 price target on the medical research company’s stock. Several other equities research analysts have also recently weighed in on AMGN. BMO Capital Markets cut their price objective on […]

@FabiGoesForGold

Германия

11 суток назад

𝘼𝙢𝙜𝙚𝙣 - 𝘼𝙧𝙤𝙪𝙣𝙙 𝟭𝟰% 𝙜𝙖𝙞𝙣 𝙨𝙞𝙣𝙘𝙚 𝙩𝙝𝙚 𝙗𝙚𝙜𝙞𝙣𝙣𝙞𝙣𝙜 𝙤𝙛 𝙩𝙝𝙞𝙨 𝙩𝙪𝙧𝙗𝙪𝙡𝙚𝙣𝙩 𝙮𝙚𝙖𝙧 The first half of 2022 has been a real test for shareholders. It is therefore gratifying to have a stock like Amgen in the portfolio. Amgen, which has gained about 14% since the beginning... Показать подробности